INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update

01 مارس 2023 07:30:35 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast

14 فبراير 2023 08:00:33 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the SVB Securities Global Biopharma Conference

08 فبراير 2023 08:00:59 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 41st Annual J.P. Morgan Healthcare Conference

03 يناير 2023 08:00:24 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Highlights New CAPLYTA Bipolar Depression Data Presentations at the American College of Neuropsychopharmacology 61st Annual Meeting

08 ديسمبر 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Participate at Two Upcoming Investor Conferences

10 نوفمبر 2022 08:00:03 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update

03 نوفمبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Third Quarter 2022 Financial Results Conference Call and Webcast

27 أكتوبر 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update

09 أغسطس 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Second Quarter 2022 Financial Results Conference Call and Webcast

02 أغسطس 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Highlights Lumateperone Bipolar Depression Data Presentations at the 2022 International Society for Bipolar Disorders (ISBD) Experience

13 يونيو 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update

10 مايو 2022 07:30:01 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host First Quarter 2022 Financial Results Conference Call and Webcast

03 مايو 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA® (lumateperone) for Specific Patient Populations

25 أبريل 2022 07:00:01 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors

21 أبريل 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 21st Annual Needham Virtual Healthcare Conference

05 أبريل 2022 08:00:03 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update

01 مارس 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast

22 فبراير 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 11th Annual SVB Leerink Global Healthcare Conference

10 فبراير 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Closing of $460 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

07 يناير 2022 16:01:00 بحسب Nasdaq GlobeNewswire